Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Revolution Medicines (RVMD) Change in Receivables: 2018-2024

Historic Change in Receivables for Revolution Medicines (RVMD) over the last 7 years, with Dec 2024 value amounting to -$1.3 million.

  • Revolution Medicines' Change in Receivables fell 84.96% to -$1.3 million in Q1 2024 from the same period last year, while for Mar 2024 it was -$4.0 million, marking a year-over-year decrease of 187.82%. This contributed to the annual value of -$1.3 million for FY2024, which is 63.32% up from last year.
  • According to the latest figures from FY2024, Revolution Medicines' Change in Receivables is -$1.3 million, which was up 63.32% from -$3.4 million recorded in FY2023.
  • Over the past 5 years, Revolution Medicines' Change in Receivables peaked at -$464,000 during FY2021, and registered a low of -$3.4 million during FY2023.
  • In the last 3 years, Revolution Medicines' Change in Receivables had a median value of -$1.3 million in 2022 and averaged -$2.0 million.
  • In the last 5 years, Revolution Medicines' Change in Receivables plummeted by 263.46% in 2020 and then spiked by 80.20% in 2021.
  • Over the past 5 years, Revolution Medicines' Change in Receivables (Yearly) stood at -$2.3 million in 2020, then soared by 80.20% to -$464,000 in 2021, then plummeted by 170.69% to -$1.3 million in 2022, then tumbled by 172.21% to -$3.4 million in 2023, then spiked by 63.32% to -$1.3 million in 2024.